Gladden Brian T purchased $100K of XRAY
Gladden Brian T purchased 9,985 shares of DENTSPLY SIRONA Inc. (XRAY) at $10.02 ($0.10M total) on 2026-06-15.
How this was made
The 30-second read
Why it matters
A director’s open-market purchase provides incremental sentiment information but does not change the company’s fundamentals in the text provided.
Market read
Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a sustained repricing.
What to watch
The filing notes no pre-arranged 10b5-1 plan; traders may still treat it as lower-signal without corroborating fundamental news.
Background
The article is an SEC Form 4 insider transaction disclosure for Dentsply Sirona (XRAY).
Ticker impact
Dentsply Sirona director Brian T Gladden filed an open-market purchase of 9,985 shares at $10.0150 on 2026-06-15.
Likely limited near-term impact; any effect is typically small and fades unless followed by additional disclosures or fundamentals.
The filing is a routine insider transaction (director open-market purchase) with no accompanying guidance, deal, or operational update.
Market effects
No clear sector read-through; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Insider open-market buys are often discretionary and may reflect diversification, liquidity planning, or routine compensation-related behavior rather than a new bullish thesis.
Key entities
- issuerDentsply Sirona Inc.
Subject of the SEC Form 4 insider transaction disclosure (XRAY).
- insiderGladden Brian T
Director who purchased 9,985 shares on 2026-06-15.
